Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma

Bibliographic Details
Main Author: McGettigan, Suzanne
Format: Online
Language:English
Published: Harborside Press 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114496/
id pubmed-4114496
recordtype oai_dc
spelling pubmed-41144962014-08-01 Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma McGettigan, Suzanne Review Article Harborside Press 2014 2014-05-01 /pmc/articles/PMC4114496/ /pubmed/25089220 Text en Copyright © 2014, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author McGettigan, Suzanne
spellingShingle McGettigan, Suzanne
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
author_facet McGettigan, Suzanne
author_sort McGettigan, Suzanne
title Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_short Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_full Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_fullStr Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_full_unstemmed Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
title_sort dabrafenib: a new therapy for use in braf-mutated metastatic melanoma
description
publisher Harborside Press
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114496/
_version_ 1613118900436729856